INDEXED STUDIES
Thymalin — Indexed Studies
50 most recent studies indexed by PSI from PubMed and clinical databases
Showing 50 of 50 studies
Circulating Mitochondrial Open Reading Frame of the 12S Ribosomal RNA Type-c Is Higher in Acute Coronary Syndrome and Is a Prognostic Biomarker for Major Cardiac Events in Patients With Acute Myocardial Infarction: A Case-Control Study.
Cao P, Wang B, Zhang N et al.
Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization.
Elhusseiny R, Ihsan M, Labidi M et al.
Reduced serum levels of mitochondria-derived peptide MOTS-c in patients with obstructive sleep apnea.
Luo Z, Ji R, Ye R et al.
Circulating PGC-1α and MOTS-c Peptide as Potential Mitochondrial Biomarkers in Patients Undergoing Aortic Valve Replacement.
Sánchez-Quintero MJ, Iboleón A, Martín Chaves L et al.
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Neurohumoral and Mitochondrial Activation in Patients With Diabetes.
Ikonomidis I, Pavlidis G, Pliouta L et al.
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study.
Zicarelli M, Greco M, Roumeliotis S et al.
Exploring the therapeutic potential of MOTS-c in age-related macular degeneration: from cellular responses to patient-derived cybrids.
Mohtashami Z, Schneider K, Azimi R et al.
Evaluation of vascular peroxidase 1, humanin, MOTS-c and miR-200c expression levels in untreated preeclampsia patients.
Coskun E, Ekmekci OB, Gungor Z et al.
Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure.
Asil H, Demiryürek AT, Düzen IV et al.
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study.
Bolignano D, Greco M, Presta P et al.
Impact of Radiation Therapy on Serum Humanin and MOTS-c Levels in Patients with Lung or Breast Cancer.
Kavak AG, Karslioglu I, Saracaloglu A et al.
The relationship of circulating MOTS-c level with liver fibrosis and metabolic components in patients with metabolic dysfunction-associated fatty liver disease.
Kirik A, Dogru T, Yanik B et al.
Exercise and vascular function in sedentary lifestyles in humans.
Fasipe B, Li S, Laher I
Evaluation of Serum Humanin and MOTS-c Peptide Levels in Patients with COVID-19 and Healthy Subjects.
Saracaloglu A, Mete AÖ, Ucar DF et al.
Evaluation of Coronary Flow Level with Mots-C in Patients with STEMI Undergoing Primary PCI.
Çakmak T, Yaşar E, Çakmak E et al.
Serum MOTS-c levels remain unchanged in patients with preeclampsia.
Tok A, Serdar O, Kandilcik OF et al.
Circulating levels of MOTS-c in patients with breast cancer treated with metformin.
Cuyàs E, Verdura S, Martin-Castillo B et al.
MOTS-c as a predictor of coronary lesions and complexity in patients with stable coronary artery disease.
Yaşar E, Çakmak T, Bayramoğlu A et al.
Comparison of Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Levels in Patients With Multiple Sclerosis and Healthy Controls.
Tekin S, Bir LS, Avci E et al.
Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors.
Dieli-Conwright CM, Sami N, Norris MK et al.
Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans.
von Walden F, Fernandez-Gonzalo R, Norrbom J et al.
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.
Ikonomidis I, Katogiannis K, Kyriakou E et al.
aMitochondrial-Derived Peptide MOTS-c Targets SLC7A11 to Preserve Spermatogenesis by Suppressing Ferroptosis.
Liu S, Ru K, Shen YJ et al.
Mitochondrial open reading frame of the 12S rRNA type-c (MOTS-c) primes adrenal cortex metabolism without directly driving steroidogenesis.
Blatkiewicz M, Kaminski K, Sobalska-Kwapis M et al.
Effects of graviola oil extract on fattening performance and circadian rhythms of adipokine, cardiac and mitochondrial function markers in lambs.
Kotan GC, Bayraktar B
Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway.
Chen D, Zhou MH, Zhu WY et al.
MOTS-c Protects Against Acetaminophen-induced Liver Injury through the MAPK Signaling Pathway.
Li N, Xu Y, Chen Q et al.
Mitochondrial-derived peptides MOTS-c and humanin attenuate dexamethasone-induced atrophy in human skeletal muscle cells.
Elhusseiny R, Ihsan M, Bellefroid T et al.
Aerobic exercise and MOTS-c attenuate diabetic myocardial fibrosis via inhibition of the THBS1/TGF-β signaling pathway.
Li Z, Wang T, Fu Y et al.
Therapeutic Effects of MOTS-c in the Valproic Acid-Induced Autism Model in Rats: Role of Tetrahydrobiopterin and Brain-Derived Neurotrophic Factor.
Güvenir Seven S, Sahin H, Erkanlı Şentürk G et al.
Reduced serum and skeletal muscle MOTS c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction.
Kutuk IS, Akin S, Demirel H et al.
MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy.
Feng Z, Xing Y, Lou J et al.
Exogenous MOTS-c mitigates myocardial ischemia-reperfusion injury: experimental and in silico evidence from rat heart models.
Santhanam SS, Jayaraman S, Kurian GA
Systemic MOTS-c levels are increased in adults with obesity in association with metabolic dysregulation and remain unchanged after weight loss.
Yoon SH, Yuan F, Zhu X et al.
MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner.
Gudiksen A, Hansen CC, van der Stede T et al.
Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Dynamics as a Complementary Marker of Treatment Response in Newly Diagnosed Multiple Myeloma: A Prospective Analysis.
Erol V, Avci E, Kabukcu Hacioglu S et al.
Muscle-Targeted Nanocomposite Therapy Alleviates Age-Related Sarcopenia via Antioxidant and Metabolic Reprogramming.
Liu Z, Shen Z, Lu H et al.
Insights into the Biomarker Potential of Humanin and Mots-c Expression and Telomere Length in Alzheimer's Disease.
Rodríguez-Esparragón F, Cazorla-Rivero SE, Torrealba E et al.
MOTS‑c protects against placental injury via Nrf2 activation in hypoxia‑induced intrauterine growth restriction mice.
Chen D, Zhao HM, Sun XL et al.
MOTS-c attenuates mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via an Nrf2-Dependent Mechanism.
Li K, Yang T, Chen F et al.
MOTS-C levels ın ındividuals with and without obesity and ıts association with ınflammation, insulin resistance and endothelial dysfunction.
Ozkaya DY, Haymana C, Demirci I et al.
Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes.
Kong BS, Lee H, L'Yi S et al.
Retrospective study on the value of serum angiopoietin 2 and cystatin C levels in the early diagnosis of acute coronary syndrome.
Zou Q, Huang Y, Peng Y et al.
Characterization of the Avian Mitochondrial-Derived Peptide MOTS-c and Its Potential Role as a Metabolic Regulator.
Shu X, Liu J, Xu B et al.
Diagnostic relevance of Humanin, GAS5 and miR-21/miR-103 in prostate disease risk stratification.
Coradduzza D, Cruciani S, Sibono L et al.
A mitochondrial-derived peptide MOTS-c contributes to the protective effect against brain injury associated with LPS-induced sepsis by strengthening the blood-brain barrier's ultrastructure.
Bai Y, Wu H, Wang X et al.
Mitochondria-derived peptide MOTS-c restores mitochondrial respiration in type 2 diabetic heart.
Pham T, Taberner A, Hickey A et al.
The impact of mitokine MOTS-c administration on the soleus muscle of rats subjected to a 7-day hindlimb suspension.
Sidorenko DA, Lvova ID, Tyganov SA et al.
Mitochondria-derived peptide MOTS-c and its role in OSA pathogenesis: a potential therapeutic target?
Edwards BA, Joosten SA, Landry SA
MOTS-c-modified functional self-assembly peptide hydrogels enhance the activity of nucleus pulposus-derived mesenchymal stem cells of intervertebral disc degeneration.
Lin Y, Yang RY, Li J et al.
Considering peptide therapy?
Find a vetted physician in our directory who specializes in evidence-based peptide protocols.
Find a Physician